update2017
HECへのオランザピン(ジプレキサ)
ステロイド+5HT3拮抗剤+アプレピタントへのオランザピン10mg上乗せで制吐効果が増加する/NEJM
![Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting - PubMed](cache/ogp/3228bb4e4a48cf91faaf671830cf9161.jpg)
Olanzapine, as compared with placebo, significantly improved nausea prevention, as well as the complete-response rate, among previously untreated patients who were receiving highly emetogenic chemotherapy. (Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT02116530.).
https://www.ncbi.nlm.nih.gov/pubmed/27410922
日本人でのデータ。ステロイド+5HT3拮抗剤(パロノセトロン)+アプレピタントへのオランザピン5mg上乗せで制吐効果が増加する/Int J Clin Oncol
![A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy - PubMed](cache/ogp/ad46bc3b8f54391a7becebab3176fde1.jpg)
UMIN000014214.
https://www.ncbi.nlm.nih.gov/pubmed/29039073
HECへのサリドマイド
HECによる遅発性嘔吐をサリドマイドがよく抑制するという話。パロノセトロンとステロイドに制吐剤としてのサリドマイドの併用で完全制御率が15%ほどアップ。ただし避妊に注意(強い縛りあり)。/JCO
![Efficacy of Thalidomide in Preventing Delayed Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase III Trial (CLOG1302 study) - PubMed](cache/ogp/c32d5d53977ce9e367341568b126c366.jpg)
Purpose We examined the efficacy and safety of thalidomide (THD) for the prevention of delayed nausea and vomiting in patients who received highly emetogenic chemotherapy (HEC). Patients and Methods In a randomized, double-blind, active-controlled, phase III trial, chemotherapy-naive patients with c …
https://www.ncbi.nlm.nih.gov/pubmed/28854065
この記事に対するコメント
このページには、まだコメントはありません。
更新日:2019-12-16 閲覧数:1067 views.